Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD)
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Depressive Disorder, Major
In brief
The study will evaluate the efficacy, safety, and tolerability of 450 milligrams (mg) or 225 mg of Rapastinel compared to placebo in the prevention of relapse in participants with major depressive disorder (MDD).
Key facts
- Study ID
- NCT03614156
- Run by
- Naurex, Inc, an affiliate of Allergan plc
- People needed
- 363
- Starts
- 2018-08-02
- Expected to finish
- 2019-07-11
- Last updated by the study team
- 2020-10-09
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Woodland International Research Group — Little Rock, Arkansas, United States
- California Pharmaceutical Research Institute — Anaheim, California, United States
- Synergy Research San Diego — National City, California, United States
- Excell Research Inc. — Oceanside, California, United States
- NRC Research Institute — Orange, California, United States
- Artemis Institute for Clinical Research — San Diego, California, United States
- California Neuroscience Research Medical Group,Inc. — Sherman Oaks, California, United States
- Viking Clinical Research Ltd. — Temecula, California, United States
- Pacific Clinical Research Medical Group — Upland, California, United States
- Research Centers of America — Hollywood, Florida, United States
- Clinical NeuroscienceSolutions, Inc. — Jacksonville, Florida, United States
- Innovative Clinical Research, Inc. — Lauderhill, Florida, United States
- Innova Clinical Trials — Miami, Florida, United States
- Atlanta Center for Medical Research — Atlanta, Georgia, United States
- Institute for Advanced Medical Research — Atlanta, Georgia, United States
- iResearch Atlanta, LLC — Decatur, Georgia, United States
- Iris Research, Inc. — Smyrna, Georgia, United States
- Alexian Brothers Center for Psychiatric Research — Hoffman Estates, Illinois, United States
- Capstone Clinical Research — Libertyville, Illinois, United States
- Pharmasite Research, Inc. — Baltimore, Maryland, United States
- CBH Health — Gaithersburg, Maryland, United States
- Boston Clinical Trials — Boston, Massachusetts, United States
- Adams Clinical — Watertown, Massachusetts, United States
- Precise Research Centers — Flowood, Mississippi, United States
- Alea Research — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.